1. Home
  2. ADAG vs DLHC Comparison

ADAG vs DLHC Comparison

Compare ADAG & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • DLHC
  • Stock Information
  • Founded
  • ADAG 2011
  • DLHC 1969
  • Country
  • ADAG China
  • DLHC United States
  • Employees
  • ADAG N/A
  • DLHC N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • DLHC Business Services
  • Sector
  • ADAG Health Care
  • DLHC Consumer Discretionary
  • Exchange
  • ADAG Nasdaq
  • DLHC Nasdaq
  • Market Cap
  • ADAG 90.8M
  • DLHC 79.6M
  • IPO Year
  • ADAG 2021
  • DLHC N/A
  • Fundamental
  • Price
  • ADAG $2.00
  • DLHC $5.60
  • Analyst Decision
  • ADAG Strong Buy
  • DLHC
  • Analyst Count
  • ADAG 1
  • DLHC 0
  • Target Price
  • ADAG $8.00
  • DLHC N/A
  • AVG Volume (30 Days)
  • ADAG 94.7K
  • DLHC 23.3K
  • Earning Date
  • ADAG 08-05-2025
  • DLHC 08-06-2025
  • Dividend Yield
  • ADAG N/A
  • DLHC N/A
  • EPS Growth
  • ADAG N/A
  • DLHC 75.08
  • EPS
  • ADAG N/A
  • DLHC 0.38
  • Revenue
  • ADAG $103,204.00
  • DLHC $377,074,000.00
  • Revenue This Year
  • ADAG $6,488.89
  • DLHC N/A
  • Revenue Next Year
  • ADAG $57.50
  • DLHC N/A
  • P/E Ratio
  • ADAG N/A
  • DLHC $15.19
  • Revenue Growth
  • ADAG N/A
  • DLHC N/A
  • 52 Week Low
  • ADAG $1.33
  • DLHC $2.72
  • 52 Week High
  • ADAG $3.58
  • DLHC $11.78
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 56.27
  • DLHC 48.97
  • Support Level
  • ADAG $1.87
  • DLHC $5.68
  • Resistance Level
  • ADAG $2.17
  • DLHC $5.92
  • Average True Range (ATR)
  • ADAG 0.17
  • DLHC 0.18
  • MACD
  • ADAG 0.01
  • DLHC -0.02
  • Stochastic Oscillator
  • ADAG 71.93
  • DLHC 26.67

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

About DLHC DLH Holdings Corp.

DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.

Share on Social Networks: